Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
New Haven, CT, April 05, 2018 (GLOBE NEWSWIRE) -- The cognitive science company, Cogstate Ltd (ASX.CGS) today announced the establishment of a Rare Disease and Pediatric Center of Excellence to lead...
-
SAN FRANCISCO, April 04, 2018 (GLOBE NEWSWIRE) -- BrainChip Holdings Ltd. (“BrainChip” or the “Company”) (ASX:BRN), a leading developer of software and hardware accelerated solutions for advanced...
-
Highlights MHA Petroleum Consultants have calculated a Prospective Resources of 3.3 TCF (Trillion Cubic Feet) net to Strata-X. (1)Represents a 240%, 1.9 TCF, increase in Prospective Resource over...
-
TORONTO, April 04, 2018 (GLOBE NEWSWIRE) -- Highlights • Cardinal’s commitment to regional exploration in Ghana has been stepped up on the strength of early results, with drill rigs testing a...
-
VANCOUVER, British Columbia, April 03, 2018 (GLOBE NEWSWIRE) -- Macarthur Minerals Limited (TSX-V:MMS) (the “Company” or “Macarthur Minerals”) is pleased to announce that Artemis Resources Limited...
-
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES PERTH, Western Australia, April 02, 2018 (GLOBE NEWSWIRE) -- Perseus Mining Limited (ASX:PRU)...
-
First two patients of the additional cohort of the Phase I, TACTI-mel trial have commenced treatment; data to be reported mid-2018AIPAC trial: 33 out of a planned 34 clinical sites now active with...
-
TORONTO, April 02, 2018 (GLOBE NEWSWIRE) -- Kirkland Lake Gold Ltd. (“Kirkland Lake Gold” or the “Company”) (TSX:KL) (NYSE:KL) (ASX:KLA) today announced the filing of a technical report for the...
-
SAN DIEGO, April 02, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced that it will...
-
NEW YORK and MELBOURNE, Australia, March 28, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that enrollment has completed in the Phase 3 trial evaluating a single...